Fresh Tracks Therapeutics Inc expected to post a loss of $1.89 a share - Earnings Preview

Fresh Tracks Therapeutics

05/11/2022 03:21

* Fresh Tracks Therapeutics Inc  FRTX.OQ   FRTX.O  is
expected
to show a rise in quarterly revenue when it reports  results on
November 10. 
    * The Boulder Colorado-based  company is expected to report 
a
225.8% increase in revenue to $430 thousand from $132 thousand a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Fresh Tracks
Therapeutics
Inc is for a loss of $1.89 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Fresh
Tracks
Therapeutics Inc is $4.5​, above​ its last closing price
of $1.74. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -1.46       -1.44      -0.01     Beat    99.3
 Mar. 31 2022  -2.55       -2.59      -3.60     Missed  -39.1
 Dec. 31 2021  -3.84       -3.82      -2.70     Beat    29.4​
 Sep. 30 2021              -5.62      -7.20     Missed  -28
 ​​Jun.        -6.30       -5.62      -7.20     Missed  -28
 30 2021                                                
 Mar. 31 2021  -5.17       -5.17      -6.75     Missed  -30.4​
 Dec. 31 2020  -4.05       -4.05      -6.75     Missed  -66.7
 Sep. 30 2020  -8.33       -8.32      -6.75     Beat    18.9
 This summary was machine generated November 5 at 03:20 GMT.  All
figures in US dollars  unless otherwise stated